Browse By: Country ι Category ι Latest Reports ι Tag

Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors

Pages » 301
Published By » La Merie Publishing
Price » $2092
In stock
View Report Details
Description

Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets: Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) G-CSF & GM-CSF Thrombopoietin & Thrombopoiesis Stimulating Agents Interferon Insulin Coagulation Factors Human Growth Hormone (hGH) FSH, hCG and LH: Therapeutic Pro... Click here for more details


Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
GBI Research\'s report, “Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies”, provides the key data and analyzes the major challenges and drivers for the downstream industry. The report also ana
Published Date: Nov 2010
Price: $3500
Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
GBI Research has released its research Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues. It provides a comprehensive overview of the generic drugs market, analysis of upcoming noteworthy patent expirations, and trends and issue
Published Date: May 2011
Price: $3500
Interventional Cardiology (Devices & Technology) - Global Trends, Estimates and Forecasts, 2012-2018
Global Market Watch: Global Interventional Cardiology market is estimated to reach US$22.2 billion by 2016. Global Interventional Cardiac Devices Industry market is worth US$20.6 billion by 2016, growing at a CAGR of 9.2% for the analysis period 2012-2018 respectively. North American region
Published Date: Nov 2014
Price: $4450
Top 200 Biopharmaceutical Companies (Global)
This report is an in-depth financial evaluation of the GlobalBiopharmaceutical Companies. Using the unique Plimsoll method of analysis, each of the top 200 companies included is individually assessed and ranked against each other and compared to industry averages.Using the most up-to-date financ
Published Date: Jul 2012
Price: $1500
Research Report on Chinese Bio-pharmaceutical Industry, 2012
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In China, animal vaccine belongs to veterinary medicine rather than biopharmaceutical industry. \"B
Published Date: Mar 2012
Price: $3000
Insulin - Global
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in global markets. The analyses provide essential market information for decision-makers including:  Argentina, Armenia, Australia, Austria, Azerbaij
Published Date: May 2012
Price: $25922
Insulin - Europe
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in European markets. The analyses provide essential market information for decision-makers including:  Armenia, Austria, Azerbaijan, Belgium, Bulgari
Published Date: May 2012
Price: $14640
Insulin - Asia
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in Asian markets. The analyses provide essential market information for decision-makers including:  Bangladesh, China, India, Indonesia, Iran, Japan,
Published Date: May 2012
Price: $10620
Insulin - Americas
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in American markets. The analyses provide essential market information for decision-makers including:  Argentina, Bolivia, Canada, Chile, Colombia, E
Published Date: May 2012
Price: $5044
Insulin - Africa
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in African markets. The analyses provide essential market information for decision-makers including:  Egypt, Eritrea, Ethiopia, Ghana, Morocco, Niger
Published Date: May 2012
Price: $5044

 


 

Related News

China Persists to Bag Sri Lankan Port Construction Project
China Harbor Engineering Company (CHEC), which is a subsidiary of the state-owned China Communications Construction Company has made a proposal for the construction of new facilities at Hambantota Port in Sri Lanka. As stated by HIS Maritime 360 report, the proposal made by CHEC is focused for the construction of an all-new shipbuilding and repair dockyard. CHEC’s proposal is part of the third phase of construction of the Hambantota Port. However, CHEC is the focus of attention of th
Date: Jul 28

New York Divulges Plan for a new LaGuardia Airport
In a recent announcement, the Governor of New York revealed a plan for a new LaGuardia airport. According to the plan, the airport would be redesigned and rebuild from scratch, which would replace the cramped and outdated facility with a unified terminal that will have more than double capacity for operational space for airliners.  The Governor introduced the plan to New Yorkers delightedly, and said that the people of the city deserved it for a long time, which shall soon be true. Th
Date: Jul 28

China Selloff Deepens causing Asian Stocks to Retreat
Asian stocks, for a fifth day, retreated as the China selloff deepened. On one hand, oil dropped, and on the other, New Zealand’s currency saw a rapid increase in stocks after a near six year low. The Shanghai Composite Index dropped 3.2 per cent, while the MSCI Asia Pacific Index declined 1.1 per cent in Tokyo at 10:34 am. Futures on the Standard & Poor’s 500 Index were slightly different since the measure capped its highest running losing streak since the month of January. I
Date: Jul 28

Global Oil Benchmark Drops to Lowest since January
Brent, the global oil benchmark, dropped to its lowest price on Tuesday since the month of January amid concerns regarding the constant global oversupply of crude. US prices, on the other hand, gained ahead of the weekly inventory data. The US oil benchmark as well as the global oil benchmark Brent only recently stepped into bear markets amid worries of investors that the markets would continue the glut right till the end of the year. The bear markets are defined as a 20 per cent decline from
Date: Jul 28

Celsius Holdings Officially Granted Gluten-Free Certificate for Drinks
Celsius Holdings Inc., the Florida based company was earlier known to produce science based functional beverages such as the world’s first and only fat burning and negative calorie drink.  Now, the company has been officially granted the label of gluten-free to innovative line of drinks that have been known to be free of gluten. The certification regarding the gluten free nature of the drinks was completed by the company Merieux NutriSciences, which is an industry leader in the fie
Date: Jul 28

U.S. Securities and Exchange Commission to Investigate Complaints Regarding Manipulation of Sales Figures by Diageo plc
London-based brewer Diageo plc is trying to desperately save face after the many quarters of sales fiascos reveled about the company in recent times. First the “anti-extravagance" campaign held in China, then the receding sales from the spirits market of the U.S., lower revenues from acquisition deals and hostile currency situations in many key markets have all added to the concerns of this renowned brewer. In the past few quarters, the company has observed significant decline in sales vol
Date: Jul 28

China to Soon Surpass the Leaders in the Global Nuclear Power Market
China in terms of various electricity sectors is demonstrating high growth. This can be observed in the renewable energy sector and the non-renewable energy sector as well. China recently pledged to cut down its carbon emissions drastically, as a result of which the solar power sector in the country has received a massive boost. Another energy sector that is receiving a huge boost is the nuclear power sector. Currently, China is generating only 2 per cent of its total electricity via nuclear
Date: Jul 28

Scientists in Oman Working on Extracting Fuel out of Agricultural Waste
The shrinking natural resources are pushing scientists all over the world to come up with more sustainable and alternative energy sources. Currently, several crops such as algae and others are being researched to understand the feasibility of theirs a biofuel. Furthermore, another challenge scientist’s face is applying these alternative energy sources/biofuels in vehicles. A team of scientist and academics based in Oman have undertaken a research project to check feasibility of producin
Date: Jul 28

Wind Power Empowering the Europe’s Electricity Sector
Europe in several renewable energy sector is leading globally. Furthermore, the pledge shown by several European countries to cut down on their carbon emissions and go 100% renewable is noteworthy. Many countries are at a growing pace installing and relying on renewable energy plants that provide power to the national grid or domestic ones. In this light, a 2014 report by the Joint Research Centre (JRC) on the wind status demonstrates that in 2014, wind energy contributed to 8% of the Europe&
Date: Jul 28

Exposure to Endocrine Disrupting Chemicals Exhibit Health Threats and Accounts to €150 per Year
The exposure of humans to EDCs adds to various health abnormalities that its evaluated expenses lies between €150-260 billion for every year as indicated by another phase of study given in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism. The cost exhibits the expenses of human services costs, lost profitability and lost acquiring possibilities, the researchers behind the examination say.  An endocrine-disturbing concoction (EDC) is a synthetic or blend of ch
Date: Jul 27

Upcoming Reports

Biopharmaceutical Licensing Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
The biopharmaceutical industry is focusing on the growing complexity of licensing deals in order to secure marketing and commercialization rights within partnership deals. The major challenge faced by the biopharmaceutical licensing market is asymmetry between licensor and licensees. The biopharma
Published By: Transparency
Price: $4795
US Biopharmaceutical Market - Global Industry Size, Market Share, Smart Trends, Analysis And Forecast, 2012 - 2018
Biopharmaceuticals are medical drugs which are produced with the help of biotechnology. The US is the largest market for biopharmaceuticals and is the leader in terms of revenue, by a substantial margin. The biopharmaceutical market can be classified based on the class of the medical drug into r
Published By: Transparency
Price: $4795
Orthopedic Bone Material (Cement and Casting) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
Artificial joints have been anchored with bone cements for more than half a century. Bone cement plays the important role of an elastic zone by filling the space between the prosthesis and the bone. The necessity of bone cement is supported by the fact that the human hip is acted on by 10-12 tim
Published By: Transparency
Price: $4595
Single-Use Technologies For Biopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Single use technologies involve single-use or disposable products. Such products are usually made of plastics or its derivatives such as polyamides, polycarbonates, polyethylene, polyvinyl chloride and various others. These products are becoming popular in the biopharmaceutical applications as the
Published By: Transparency
Price: $4795